XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income
Balance beginning of period (in shares) at Dec. 31, 2023   67,807,831      
Balance beginning of period at Dec. 31, 2023 $ 1,554,044 $ 68 $ 5,468,728 $ (3,932,826) $ 18,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 2,900     2,900  
Unrealized gain (loss) on derivatives 7,319       7,319
Reclassification to interest expense, net (3,317)       (3,317)
Distributions declared (15,360)     (15,360)  
Stock-based compensation, net (in shares)   66,697      
Stock-based compensation, net 2,463   2,463    
Balance end of period (in shares) at Mar. 31, 2024   67,874,528      
Balance end of period at Mar. 31, 2024 $ 1,548,049 $ 68 5,471,191 (3,945,286) 22,076
Balance beginning of period (in shares) at Dec. 31, 2024 77,450,794 77,450,794      
Balance beginning of period at Dec. 31, 2024 $ 1,760,005 $ 77 5,730,367 (3,984,865) 14,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 6,792     6,792  
Unrealized gain (loss) on derivatives (1,586)       (1,586)
Reclassification to interest expense, net (2,242)       (2,242)
Distributions declared (18,438)     (18,438)  
Stock-based compensation, net (in shares)   116,970      
Stock-based compensation, net $ 275 $ 1 274    
Balance end of period (in shares) at Mar. 31, 2025 77,567,764 77,567,764      
Balance end of period at Mar. 31, 2025 $ 1,744,806 $ 78 $ 5,730,641 $ (3,996,511) $ 10,598